Activation of the JNK pathway is essential for transformation by the Met oncogene

The EMBO Journal
G A RodriguesJ Schlessinger

Abstract

The Met/Hepatocyte Growth Factor (HGF) receptor tyrosine kinase is oncogenically activated through a rearrangement that creates a hybrid gene Tpr-Met. The resultant chimeric p65(Tpr-Met) protein is constitutively phosphorylated on tyrosine residues in vivo and associates with a number of SH2-containing signaling molecules including the p85 subunit of PI-3 kinase and the Grb2 adaptor protein, which couples receptor tyrosine kinases to the Ras signaling pathway. Mutation of the binding site for Grb2 impairs the ability of Tpr-Met oncoprotein to transform fibroblasts, suggesting that the activation of the Ras/MAP kinase signaling pathway through Grb2 may be essential for cellular transformation. To test this hypothesis dominant-negative mutants of Grb2 with deletions of the SH3 domains were introduced into Tpr-Met transformed fibroblasts. Cells overexpressing the mutants were found to be morphologically reverted and exhibited reduced growth in soft agar. Surprisingly, the Grb2 mutants blocked activation of the JNK/SAPK but not MAP kinase activity induced by the Tpr-Met oncoprotein. Additionally, cells expressing dominant-negative Grb2 mutants had reduced PI-3-kinase activity and dominant-negative mutants of Rac1 blocked both Tpr-M...Continue Reading

References

Nov 22, 1991·Science·S A Aaronson
Jun 20, 1986·Cell·M ParkG F Vande Woude
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·M L GishizkyA M Pendergast
Mar 30, 1995·Nature·R G QiuM Symons
May 25, 1995·Nature·F MichielsJ G Collard
May 26, 1995·The Journal of Biological Chemistry·J WangT M Roberts
May 1, 1995·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·L A QuilliamC J Der
Jan 27, 1995·Cell·G B CohenD Baltimore
Feb 1, 1994·Current Opinion in Genetics & Development·G A Rodrigues, M Park
Aug 1, 1993·Trends in Biochemical Sciences·J Schlessinger
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·A B RaitanoC L Sawyers
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·R G QiuM Symons
May 31, 1996·The Journal of Biological Chemistry·E D FixmanM Park

❮ Previous
Next ❯

Citations

May 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·O KutukH Basaga
May 4, 2012·Archives of Pharmacal Research·Kyung Hee JungSoon-Sun Hong
Mar 3, 2004·Journal of the American College of Surgeons·Chad A WiesenauerC Max Schmidt
Nov 7, 1999·Journal of Hepatology·A J Smith, R P Oude Elferink
Oct 5, 2001·Free Radical Biology & Medicine·K KittaY J Suzuki
Apr 30, 1998·Current Opinion in Cell Biology·Y T Ip, R J Davis
Nov 13, 2008·Cytotechnology·T MashimaT Tsuruo
Nov 26, 2010·Nature Reviews. Molecular Cell Biology·Livio TrusolinoPaolo M Comoglio
May 15, 2007·Oncogene·A J Whitmarsh, R J Davis
Aug 4, 2001·Thyroid : Official Journal of the American Thyroid Association·S S ShklyaevS Yamashita
May 7, 2002·EMBO Reports·Moran BenharAlexander Levitzki
Jul 21, 1998·Annals of the New York Academy of Sciences·M Karin
Aug 4, 2001·Molecular and Cellular Biology·A Danilkovitch-MiagkovaE J Leonard
Sep 28, 2012·Breast Cancer Research : BCR·Richard A SteinmanSteffi Oesterreich
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·M JeffersG F Vande Woude
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·S GaniatsasL I Zon
Oct 31, 1998·Current Opinion in Genetics & Development·K Zaret
Jun 17, 2009·FEBS Letters·Ke YaoZigang Dong
Mar 15, 2013·Expert Opinion on Investigational Drugs·Sushmita ChakrabortyAbhijit Ray
Dec 30, 2014·Expert Opinion on Drug Delivery·Ana Tari Ashizawa, Jorge Cortes
Apr 15, 2008·Current Opinion in Genetics & Development·Beatrice S Knudsen, George Vande Woude
Dec 5, 2006·Journal of Molecular Biology·Holger SchmidtDieter Willbold
Sep 24, 2004·The EMBO Journal·Stéphanie KermorgantPeter J Parker
Aug 23, 2006·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Bin WangYoshiya Tanaka
May 28, 2010·Journal of Cellular Biochemistry·Angelina FeliciDonald P Bottaro
Jan 2, 2007·Biochemical and Biophysical Research Communications·Yohei ShidaHiroshi Kanetake

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.